Essay corrections Flashcards
B thal symptom explanations
Fatigue and pallor - a globin chain xs causing precipitation within the erythroblasts and damaging them. The alpha globins do not form tetramers. They cause erythroblasts to die and thus depletion of functioning haemoglobin. + Ineffective erythropoiesis
Jaundice - intravascular haemolysis as well due to abnormal RBC presence in blood.
Splenomegaly and hepatomegaly - Increased extamedullary haematopoiesis + extravascular haemolysis
Bone marrow hyperplasia -> Hypoxic environment stimulates hypoxic drive and increased EPO production. Erythropoiesis is however ineffective therefore leading to bone deformity, Bone spikules develop and the BM expands, showing up as a hair on end appearance -> osteoporosis and pathological fractures + Enlargement of maxillae other facial bones
Pulmonary HTN - Increased haemolysis means increased Hb in the circulation, this saturates the haptoglobin and then free Hb binds to NO and is oxidised to met haemoglobin . Lack of NO causes vasoconstriction, particularly affecting the pulmonary circulation
Consequences of transfusions – iron loading
Heart – Arrhythmias, cardiomyopathy, cardiac failure
Liver – cirrhosis and also hepatocellular cancer
Pancreas – diabetes
Pituitary – growth interruption and also sexual maturation
Psychosocial of transfusion dependant life (Affects education, activity, integration (Ratip et al. 1992), Anxiety in over half , 58% have difficulty with sexual maturity)
PNH mechanism references
PIGA discovery was Takeda 1993
Pathophysiology is BRODSKY 2004
Mx, xs anticoagulation not needed for proph in PNH emadi BRODSKY 2009
Microparticles -> wiedmar 1993
Free Hb - > rother 2005
C5a (IL 6, 8., TNFa) -> Ritis 2006
decreased fibrinolysis (TFPI coreceptor, decreased uro r a and heparan sulfate) -> maroney 2006
chronologically through time but opposite alphabet
Stroke prevention reference in blood transfusion
NEJM DeBaun et al. , regular blood-transfusion therapy significantly reduced the incidence of the recurrence of cerebral infarct in children with sickle cell anaemia.
• 3236 transfusions, 4/99 (4%) patients developed 9 alloAbs
• Alloimmunisation rate of 0.278/100 RBCs
Cons of blood transufsions
Haemosiderosis Iron overload
Hyperhaemolysis syndrome
Haemolytic transufion reaction (acute and delayed)
Transmission of infectious agents TRALI TACO TA-GvHD TwITCH Trial - future PTP Recurrent venous access
IVH vs EVH in SCD
IV haemolysis = free Hb in circulation = breakdown of NO = vasoconstriction and more platelet activation
ohaptoblobin and haemopexin, two mechanisms by which Free Hb is removed from the blood, are both reduced in SCD
oIV haemolysis = release of arginase = breakdown of arginine = less NO synthesis
Scavegened NO:
•Sickle vasculopathy – SCD can be described as a chronic inflammatory disease!
•Pulmonary HTN, vascular hyperplasia
Extravascular haemolysis
•metHbS is formed via oxidation. it breaks down into hemichromes and releases haem and Fe3+
•Haem and Fe3+ oxidise membrane lipids, cytoskeleton and other HbS molecules
•oxidised HbS precipitates as Heinz bodies which bind to ANKYRIN BAND 3 on inner CSM
othis is seen and removed by the spleen; extravascular haemolysis and chronic HA
Malaria essay references
1 Kyes et al. -> PfEMP1 causes Ag variation
2 Eodzien - higher IgG levels in HbAS indviduals
3 Cockburn et al. - CR1 polymorphism is association with alpha thalassemia and confers protection to severe malaria
4 Ayi et al - proposed that oxidative events led to the enhanced phagocytosis of ring staged cells in beta thal, sickle and HbH (the oxidative events were aggregation of band 3, deposition of antibodies and complement C3c frgaments).
HO-1 role?
Sickle Hb induces expression of heme oxygenase 1 in HSC via Nrf2 TF. CO (a by product of heme catabolism) by HO-1, prevents further accumulation of free Hb and limits tissue damage post Plasmodium infection
Ayi et al proposed what for malaria
Ayi et al - proposed that oxidative events led to the enhanced phagocytosis of ring staged cells in beta thal, sickle and HbH (the oxidative events were aggregation of band 3, deposition of antibodies and complement C3c frgaments).
Duffy antigen explanation + reference
LUTZ et al.
For invasions to occur an interaction between the parasites and antigens of the Duffy Blood Group System is necessary. In Caucasians six antigens are produced by the Duffy locus (Fya, Fyb, F3, F4, F5 and F6). It has been observed that Fy(a-b-) individuals are resistant to Plasmodium knowlesi and P. vivax infection, because the invasion requires at least one of these antigens. The P. vivax Duffy Binding Protein (PvDBP) is functionally important in the invasion process of these parasites in Duffy / DARC positive humans. The proteins or fractions may be considered, therefore, an important and potential innoculum to be used in immunization against malaria.
HFE mutation mechanism
The most prevalent disease-causing HFE mutation in the general population is the C282Y mutation, which disrupts the formation of a disulfide bond in the HFE protein and impairs its capability to bind β2-microglobulin. As a consequence, HFE is unable to reach the cell surface and aggregates intracellularly. This causes impaired signaling leading to reduced hepcidin mRNA expression, decreased plasma hepcidin levels, and excessive systemic iron accumulation in adults (aged over 40 years).
Hepcidin binds to FP and degrades it so low hepcidin -> hig FPN -> high absorption means that high fe export in the blood
Iron overload management
Primary
Removal of excess iron by phlebotomy
Initially once weekly until transferrin saturation <16% and ferritin <20 mcg/L then maintenance. Keep transferrin saturation <50% and ferritin <50 mcg/L indefinitely
Secondary
Deferoxamine is the drug traditionally used for iron chelation therapy. It is given by a slow subcutaneous infusion overnight through a portable pump:
• Chelation is usually by slow SC deferoixamine 20-60mg/kg/day over 8-24hrs
• Some oral iron chelators (desferiox, deferipone) are available but they have side effects (GI disturbance, neutropenia, agranulocytosis)
Lectin pathway
MBL or ficolins bind to carbohydrate moieties on bacterial surface and activate MASPS. MASPS 1 and 2 are mbl associated serine proteases which convert analogous to C1q and split C2 and C4s > C3 convertase
Alternative pathway
•C3 undergoes hydrolysis to C3(H20)
•This allows factor D to cleave Factor B into Bb and Ba
•C3(H2O)Bb is a C3 convertase cleaving C3 > C3a+b
•C3b in contact with a FOREIGN surface activates C3 amplification loop.
•C3b does two things:
1 .Opsonisation which surrounds the pathogenic surface enabling phagocytosis ( C3b molecules can attach to the Fc regions of antigen-bound antibodies leading to phagocytosis or movement to the liver, where the C3b-tagged immune complex is then destroyed)
2. C5 activation and formation of MAC
What stops complement from attacking our own cells?
This process does not occur on own cells as our cells; FLUID PHASE and MEMBRANE bound regulators to control this process. Dysregulation of these mechanisms leads to pathogenesis:
- Own cell membranes contain sialic acid which is absent from pathogenic cell membranes.
- FACTOR H in the presence of Sialic acid on self-cells regulates C3b amplification. Absence on pathogenic surfaces fails to confer protection leading to C3b accumulation (and clearance of pathogen)
- C3b on self-cells can be inactivated by FACTOR I.
aHUS mechanism
- Deficiency or polymorphisms in Factor H (which regulates the alternative pathway) confer risk of HUS in response to risk such as infection/pregnancy
- Disorder of complement regulation
- Characterized by: Haemolysis, Thrombocytopenia and Renal failure
- Complex genetic trait – multiple mutation required for manifestation.
- Associated with mutations of Factor I and MCP
pathogenesis of VOE in SCA
•VCAM1 is upregulated by the dysfunctional endothelium. it binds to reticulocytes via VLA4
•reversibly sickled cells also bind to dysfunctional endothelium and exposed ECM
o young sickle cells bind to integrins via LW antigen. LW antigen is upregulated by adrenaline so stress/adrenaline = adhesion and may lead to sickling
•The majority of adhesion is believed to occur in post-capillary venules
o RBCs elongate in capillary bed (surface area) and there is slow blood flow in the venule
o adhesion leads to retrograde capillary obstruction = ischaemia/infarction
•Vaso-occlusive disease starts after 6 months of life – HbF protects upto this point
o Painful crises (limbs/chest/abdomen) occur in 40% of patients?
o hand foot syndrome (dactylitis) in the first two years of life leads to growth delay
o adolescent sequelae include delayed puberty and priapism
SCA hyposplenism pathogenesis
- Haemolysis → Splenomegaly → recurrent sequestration crises due to infarcts →atrophy and fibrosis of spleen → hyposplenism (Howel Jolly bodies) → recurrent infections occur due to immune dysfunction, particularly malaria, pneumococcus and meningococcus
- splenomegaly usually disappears after 5 years. persistent splenomegaly may indicate thalassaemia or higher HbF
How does thrombin’s exosite structure allow its regulation
Thrombin has low affinity for fibrinogen (since fibrinogen is high concn) and once fibrin is formed thrombin remains bound to it with weak affinity so that 1 it can move about on clot surface and @F13 2 it can @PC.
Thrombin’s affinity for fibrin is WEAKER than TM so once fibrin is formed -> anticoagulant fate
What two paragraphs do you forget/mess up in thrombin essay
Thrombin’s interaction with platelets:
Thrombin activates platelets using exosite 2 to activate PAR1 and PAR4. PAR4 blocking Ab had no effect on plt @ by thrombin, but when combined with PAR1 Ab it wasn’t activated even in high concn of thrombin
Thrombin’s interaction with TAFI - is PROcoagulant and uses exo 1 (if cs exo 2) Thrombin alongside TM activate TAFI. TAFI removes lysine residues on fibrin meaning that Plasminogen and tpa cannot recognise fibrin using their kringle domains (wang et al.). Removing lysine residues also partially digests fibrin which casues an associated decreased in plasminogen binding and retardation in clot lysis
DIC mechanism in APML + reference
Other APML references
Shanshank et al. -> promyelocytes produce a lot of TF which bind to FVII-> Hypercoagulable blood
FALANGA et al. ->
APL also secrete inflammatory cytokines (IL Ib) which induce TF in EC, microparticles are released -> Hypercoaguation
MENELL et al. 15;17 -> really high levels of ANNEXIN which is a cofactor for tPA that increases its formation by 60 fold. This alongside increased elastase production by APML (which degrades fibrin inhibitors) leads to»_space; Hyperfibrinolysis
Pethema Protcol. Frank et al. for DS, ATO gives 72% CR (Sun et al.)
APML FMN
- Beaware of other variant translocations 11;17 (resistant to ATRA)
- Mx: ATRA has 90% cure rate for those who survive DS. Platelets are given to keep counts 30-50 and cryo given to keep fibrinogen >1.5g/L. ATO has 72% Sun et al.